Skip to main content

Advertisement

SpringerLink
Log in

Local excision following chemoradiotherapy in T2–T3 rectal cancer: current status and critical appraisal

  • Review Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

Local excision following chemoradiotherapy in rectal cancer is an organ-preserving procedure which aims at reducing morbidity and functional disorders associated with total mesorectal excision (TME) in selected patients. Although TME after chemoradiotherapy remains the gold standard for locally advanced mid and low rectal cancer, in the last years multicenter research trials have offered encouraging oncologic results which have allowed to preserve the rectum in patients with a pathologic complete response after chemoradiotherapy. A review of the available literature on this topic was conducted to define the state of the art of this conservative approach and to focus on the most controversial aspects concerning local excision performed after chemoradiotherapy, in particular tumor scatter and lymph node status, completion and salvage surgery, morbidity and quality of life. The analysis of these topics should be considered, in trial setting or in current practice, for their clinical implications. Oncologic outcomes of recent trials are encouraging for part of the patients presenting T2 rectal cancer; however, TME still remains the standard treatment in clinical practice. In such cases, local excision should include a surgical safety margin of at least 1 cm from the resection margin to achieve a true negative margin from residual tumor cells. The selection of the patients should be carefully performed and their consensus extremely detailed because TME is necessary in about 30% of cases. Failing that, morbidity and quality of life are negatively affected. However, about half of these patients refuse radical surgery (45%), thus undergoing only palliative care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dattani M, Heald RJ, Goussous G et al (2018) Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis. Ann Surg 268(6):955–967. https://doi.org/10.1097/sla.0000000000002761

    Article  PubMed  Google Scholar 

  2. Hanly AM, Ryan EM, Rogers AC, McNamara DA, Madoff RD, Winter DC (2014) Multicenter evaluation of rectal cancer reimaging post neoadjuvant (MERRION) therapy. Ann Surg 259(4):723–727. https://doi.org/10.1097/sla.0b013e31828f6c91

    Article  PubMed  Google Scholar 

  3. Sclafani F, Brown G, Cunningham D et al (2017) Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Br J Cancer 117(10):1478–1485. https://doi.org/10.1038/bjc.2017.320

    Article  PubMed  PubMed Central  Google Scholar 

  4. Borstlap WAA, van Oostendorp SE, Klaver CEL et al (2018) Organ preservation in rectal cancer: a synopsis of current guidelines. Color Dis 20(3):201–210. https://doi.org/10.1111/codi.13960

    Article  Google Scholar 

  5. Hallam S, Messenger DE, Thomas MG (2016) A systematic review of local excision after neoadjuvant therapy for rectal cancer: are ypT0 tumors the limit? Dis Colon Rectum 59(10):984–997. https://doi.org/10.1097/dcr.0000000000000613

    Article  PubMed  Google Scholar 

  6. Lezoche E, Baldarelli M, Lezoche G, Paganini AM, Gesuita R, Guerrieri M (2012) Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg 99(9):1211–1218. https://doi.org/10.1002/bjs.8821

    Article  CAS  PubMed  Google Scholar 

  7. Shaikh I, Askari A, Ourû S, Warusavitarne J, Athanasiou T, Faiz O (2014) Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 30(1):19–29. https://doi.org/10.1007/s00384-014-2045-1

    Article  PubMed  Google Scholar 

  8. Garcia-Aguilar J, Renfro LA, Chow OS et al (2015) Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol 16(15):1537–1546. https://doi.org/10.1016/s1470-2045(15)00215-6

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lee L, Kelly J, Nassif GJ et al (2017) Chemoradiation and local excision for T2N0 rectal cancer offers equivalent overall survival compared to standard resection: a national cancer database analysis. J Gastrointest Surg 21(10):1666–1674. https://doi.org/10.1007/s11605-017-3536-5

    Article  PubMed  Google Scholar 

  10. Rullier E, Rouanet P, Tuech JJ et al (2017) Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Lancet 390(10093):469–479. https://doi.org/10.1016/s0140-6736(17)31056-5

    Article  PubMed  Google Scholar 

  11. Stijns RCH, De Graaf EJR, Punt CJA et al (2018) Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study. JAMA Surg. https://doi.org/10.1001/jamasurg.2018.3752

    Article  PubMed Central  Google Scholar 

  12. Habr-Gama A, São Julião GP, Vailati BB et al (2017) Organ preservation in cT2N0 rectal cancer after neoadjuvant chemoradiation therapy: the impact of radiation therapy dose-escalation and consolidation chemotherapy. Ann Surg 269(1):0-5. https://doi.org/10.1097/sla.0000000000002447

    Article  Google Scholar 

  13. Van Den Broek JJ, Van Der Wolf FSW, Lahaye MJ et al (2017) Accuracy of MRI in restaging locally advanced rectal cancer after preoperative chemoradiation. Dis Colon Rectum 60(3):274–283. https://doi.org/10.1097/dcr.0000000000000743

    Article  PubMed  Google Scholar 

  14. Zhao R, Wang H, Zhou Z, Zhou Q, Mulholland MW (2014) Restaging of locally advanced rectal cancer with magnetic resonance imaging and endoluminal ultrasound after preoperative chemoradiotherapy: a systemic review and meta-analysis. Dis Colon Rectum 57(3):388–395. https://doi.org/10.1097/dcr.0000000000000022

    Article  PubMed  Google Scholar 

  15. Smith FM, Wiland H, Mace A, Pai RK, Kalady MF (2014) Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy. Dis Colon Rectum 57(3):311–315. https://doi.org/10.1097/dcr.0b013e3182a84eba

    Article  PubMed  Google Scholar 

  16. Perez RO, Habr-Gama A, Pereira GV et al (2012) Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer? Color Dis 14(6):714–720. https://doi.org/10.1111/j.1463-1318.2011.02761.x

    Article  CAS  Google Scholar 

  17. Smith FM, Wiland H, Mace A, Pai RK, Kalady MF (2015) Assessment of a novel, full-thickness incisional biopsy model to restage rectal tumours after neoadjuvant chemoradiotherapy: results of an ex vivo pilot study. Tech Coloproctol 19(3):159–164. https://doi.org/10.1007/s10151-015-1272-y

    Article  CAS  PubMed  Google Scholar 

  18. Verseveld M, De Graaf EJR, Verhoef C et al (2015) Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study). Br J Surg 102(7):853–860. https://doi.org/10.1002/bjs.9809

    Article  CAS  PubMed  Google Scholar 

  19. Hayden DM, Jakate S, Pinzon MCM et al (2012) Tumor scatter after neoadjuvant therapy for rectal cancer: are we dealing with an invisible margin? Dis Colon Rectum 55(12):1206–1212. https://doi.org/10.1097/dcr.0b013e318269fdb3

    Article  PubMed  Google Scholar 

  20. Smith FM, Wiland H, Mace A, Pai RK, Kalady MF (2014) Depth and lateral spread of microscopic residual rectal cancer after neoadjuvant chemoradiation: implications for treatment decisions. Color Dis 16(8):610–615. https://doi.org/10.1111/codi.12608

    Article  CAS  Google Scholar 

  21. Perez RO, Habr-Gama A, Smith FM et al (2014) Fragmented pattern of tumor regression and lateral intramural spread may influence margin appropriateness after TEM for rectal cancer following neoadjuvant CRT. J Surg Oncol 109(8):853–858. https://doi.org/10.1002/jso.23571

    Article  PubMed  Google Scholar 

  22. Duldulao MP, Lee W, Streja L et al (2013) Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer. Dis Colon Rectum 56(2):142–149. https://doi.org/10.1097/dcr.0b013e31827541e2

    Article  PubMed  PubMed Central  Google Scholar 

  23. Tanaka S, Martling A, Lindholm J, Holm T, Palmer G (2015) Remaining cancer cells within the fibrosis after neo-adjuvant treatment for locally advanced rectal cancer. Eur J Surg Oncol 41(9):1204–1209. https://doi.org/10.1016/j.ejso.2015.05.019

    Article  CAS  PubMed  Google Scholar 

  24. Park IJ, You YN, Skibber JM et al (2013) Comparative analysis of lymph node metastases in patients with ypt0–2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum 56(2):135–141. https://doi.org/10.1097/dcr.0b013e318278ff8a

    Article  PubMed  PubMed Central  Google Scholar 

  25. Shwaartz C, Haim N, Rosin D, Lawrence Y, Gutman M, Zmora O (2015) Regional lymph node status after neoadjuvant chemoradiation of rectal cancer producing a complete or near complete rectal wall response. Color Dis 17(7):595–599. https://doi.org/10.1111/codi.12902

    Article  CAS  Google Scholar 

  26. Vallam KC, Engineer R, Desouza A, Patil P, Saklani A (2016) High nodal positivity rates even in good clinical responders after chemoradiation of rectal cancer: is organ preservation feasible? Color Dis 18(10):976–982. https://doi.org/10.1111/codi.13114

    Article  CAS  Google Scholar 

  27. Sprenger T, Rothe H, Conradi LC et al (2016) Stage-dependent frequency of lymph node metastases in patients with rectal carcinoma after preoperative chemoradiation: results from the CAO/ARO/AIO-94 trial and from a comparative prospective evaluation with extensive pathological workup. Dis Colon Rectum 59(5):377–385. https://doi.org/10.1097/dcr.0000000000000570

    Article  PubMed  Google Scholar 

  28. Yeo SG, Kim DY, Kim TH et al (2010) Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01). Ann Surg 252(6):998–1004. https://doi.org/10.1097/sla.0b013e3181f3f1b1

    Article  PubMed  Google Scholar 

  29. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646

    Article  CAS  PubMed  Google Scholar 

  30. Peeters KCMJ, Marijnen CAM, Nagtegaal ID et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246(5):693–701. https://doi.org/10.1097/01.sla.0000257358.56863.ce

    Article  PubMed  Google Scholar 

  31. van Gijn W, Marijnen CAM, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12(6):575–582. https://doi.org/10.1016/s1470-2045(11)70097-3

    Article  PubMed  Google Scholar 

  32. Perez RO, Habr-Gama A, Lynn PB et al (2013) Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. Dis Colon Rectum 56(1):6–13. https://doi.org/10.1097/dcr.0b013e318273f56f

    Article  PubMed  Google Scholar 

  33. Guerrieri M, Gesuita R, Ghiselli R, Lezoche G, Budassi A, Baldarelli M (2014) Treatment of rectal cancer by transanal endoscopic microsurgery: experience with 425 patients. World J Gastroenterol 20(28):9556–9563. https://doi.org/10.3748/wjg.v20.i28.9556

    Article  PubMed  PubMed Central  Google Scholar 

  34. Pham TT, Liney G, Wong K et al (2017) Study protocol: multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer. BMC Cancer 17(1):1–6. https://doi.org/10.1186/s12885-017-3449-4

    Article  CAS  Google Scholar 

  35. Chen Z, Liu Z, Deng X, Warden C, Li W, Garcia-Aguilar J (2012) Chromosomal copy number alterations are associated with persistent lymph node metastasis after chemoradiation in locally advanced rectal cancer. Dis Colon Rectum 55(6):677–685. https://doi.org/10.1097/dcr.0b013e31824f873f

    Article  PubMed  PubMed Central  Google Scholar 

  36. Quaresima S, Paganini AM, D’Ambrosio G, Ursi P, Balla A, Lezoche E (2017) A modified sentinel lymph node technique combined with endoluminal loco-regional resection for the treatment of rectal tumours: a 14-year experience. Color Dis 19(12):1100–1107. https://doi.org/10.1111/codi.13768

    Article  CAS  Google Scholar 

  37. Eid Y, Alves A, Lubrano J, Menahem B (2018) Does previous transanal excision for early rectal cancer impair surgical outcomes and pathologic findings of completion total mesorectal excision? Results of a systematic. J Visc Surg 155(6):445–452. https://doi.org/10.1016/j.jviscsurg.2018.03.008

    Article  CAS  PubMed  Google Scholar 

  38. Van Gijn W, Brehm V, De Graaf E et al (2013) Unexpected rectal cancer after TEM: outcome of completion surgery compared with primary TME. Eur J Surg Oncol 39(11):1225–1229. https://doi.org/10.1016/j.ejso.2013.08.003

    Article  Google Scholar 

  39. Hompes R, Mcdonald R, Buskens C et al (2013) Completion surgery following transanal endoscopic microsurgery: assessment of quality and short- and long-term outcome. Color Dis 15:576–581. https://doi.org/10.1111/codi.12381

    Article  Google Scholar 

  40. Pucciarelli S, De Paoli MDA, Guerrieri MDM et al (2013) Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum 12:1349–1356. https://doi.org/10.1097/dcr.0b013e3182a2303e

    Article  Google Scholar 

  41. Pucciarelli S, Giandomenico F, De Paoli A et al (2017) Bowel function and quality of life after local excision or total mesorectal excision following chemoradiotherapy for rectal. Br J Surg 104:138–147. https://doi.org/10.1002/bjs.10318

    Article  CAS  PubMed  Google Scholar 

  42. Nair RM, Siegel EM, Chen D et al (2008) Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum. J Gastrointest Surg 12:1797–1806. https://doi.org/10.1007/s11605-008-0647-z

    Article  PubMed  Google Scholar 

  43. Bujko K, Richter P, Smith FM et al (2013) Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders: a prospective multicentre study. Radiother Oncol 106:198–205. https://doi.org/10.1016/j.radonc.2012.12.005

    Article  PubMed  Google Scholar 

  44. Rizzo G, Zaccone G, Magnocavallo M, Mattana C (2017) Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer. Eur J Surg Oncol 43(8):1488–1493. https://doi.org/10.1016/j.ejso.2017.05.011

    Article  CAS  PubMed  Google Scholar 

  45. Jones HJS, Cunningham C, Nicholson GA (2017) Outcomes following completion and salvage surgery for early rectal cancer: a systematic review. Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2017.10.212

    Article  PubMed  Google Scholar 

  46. Bikhchandani Jai, Ong Gabie K, Eric J, Dozois KLM (2015) Outcomes of salvage surgery for cure in patients with locally recurrent disease after local excision of rectal cancer. Dis Colon Rectum 58:283–287. https://doi.org/10.1097/dcr.0000000000000283

    Article  PubMed  Google Scholar 

  47. Perez RO, Habr-gama A, Sa GP et al (2015) Transanal endoscopic microsurgery (TEM) following neoadjuvant chemoradiation for rectal cancer: outcomes of salvage resection for local recurrence. Ann Surg Oncol 23(4):1143–1148. https://doi.org/10.1245/s10434-015-4977-2

    Article  PubMed  Google Scholar 

  48. Stipa F, Picchio M, Burza A, Soricelli E, Vitelli CE (2013) Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer. Dis Colon Rectum 57(11):1245–1252. https://doi.org/10.1097/dcr.0000000000000221

    Article  Google Scholar 

  49. Rullier E, Laurent C, Bretagnol T et al (2005) Sphincter-saving resection for all rectal carcinomas. The end of the 2-cm distal rule. Ann Surg 241:465–469. https://doi.org/10.1097/01.sla.0000154551.06768.e1

    Article  PubMed  PubMed Central  Google Scholar 

  50. Martin ST, Heneghan HM, Winter DC (2012) Systematic review of outcomes after intersphincteric resection for low rectal cancer. Br J Surg 99:603–612. https://doi.org/10.1002/bjs.8677

    Article  CAS  PubMed  Google Scholar 

  51. Tsukamoto S, Miyake M, Shida D et al (2018) Intersphincteric resection has similar long-term oncologic outcomes compared with abdominoperineal resection for low rectal cancer without preoperative therapy: results of propensity score analyses. Dis Colon Rectum 9:1035–1042. https://doi.org/10.1097/dcr.0000000000001155

    Article  Google Scholar 

  52. Akagi Y, Shirouzu K, Ogata Y, Kinugasa T (2013) Oncologic outcomes of intersphincteric resection without preoperative chemoradiotherapy for very low rectal cancer. Surg Oncol 22:144–149. https://doi.org/10.1016/j.suronc.2013.03.003

    Article  PubMed  Google Scholar 

  53. Yamada K, Ogata S, Saiki Y et al (2009) Long-term results of intersphincteric resection for low rectal cancer. Dis Colon Rectum 6:1065–1071. https://doi.org/10.1007/dcr.0b013e31819f5fa2

    Article  Google Scholar 

  54. Watanabe T, Itabashi M, Shimada Y et al (2015) Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol 20:207–239. https://doi.org/10.1007/s10147-015-0801-z

    Article  PubMed  PubMed Central  Google Scholar 

  55. Park JS, Park SY, Kim HJ et al (2019) Long-term oncologic outcomes after neoadjuvant chemoradiation followed by intersphincteric resection with coloanal anastomosis for locally advanced low rectal cancer. Dis Colon Rectum 4:408–416. https://doi.org/10.1097/dcr.0000000000001321

    Article  Google Scholar 

  56. Saito N, Ito M, Kobayashi A, Nishizawa Y et al (2014) Long-term outcomes after intersphincteric resection for low-lying rectal cancer. Ann Surg Oncol 21:3608–3615. https://doi.org/10.1245/s10434-014-3762-y

    Article  PubMed  Google Scholar 

  57. Weiser MR, Quah H, Shia J et al (2009) Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg 249:236–242. https://doi.org/10.1097/sla.0b013e318195e17c

    Article  PubMed  Google Scholar 

  58. Yamada K, Saiki Y, Takano S et al (2019) Long-term results of intersphincteric resection for low rectal cancer in Japan. Surg Today 49:275–285. https://doi.org/10.1007/s00595-018-1754-4

    Article  PubMed  Google Scholar 

  59. Habr-gama A, Lynn PB et al (2016) Impact of organ-preserving strategies on anorectal function in patients with distal rectal cancer following neoadjuvant chemoradiation. Dis Colon Rectum 4:264–269. https://doi.org/10.1097/dcr.0000000000000543

    Article  Google Scholar 

  60. Perez RO, Habr-gama A et al (2011) Transanal endoscopic microsurgery for residual pain and hospital readmission rates. Dis Colon Rectum 54:545–551. https://doi.org/10.1007/dcr.0b013e3182083b84

    Article  PubMed  Google Scholar 

  61. Marks JH, Valsdottir EB, DeNittis A et al (2009) Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapy. Surg Endosc 23:1081–1087. https://doi.org/10.1007/s00464-009-0326-5

    Article  PubMed  Google Scholar 

  62. Coco C, Rizzo G, Mattana C et al (2013) Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. Surg Endosc 27(8):2860–2867. https://doi.org/10.1007/s00464-013-2842-6

    Article  CAS  PubMed  Google Scholar 

  63. Gornicki A, Richter P, Polkowski W, Szczepkowski M (2014) Anorectal and sexual functions after preoperative radiotherapy and full-thickness local excision of rectal cancer. Eur J Surg Oncol 40(6):723–730. https://doi.org/10.1016/j.ejso.2013.11.010

    Article  CAS  PubMed  Google Scholar 

  64. D’Ambrosio G, Paganini AM, Balla A et al (2016) Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision. Surg Endosc 30(2):504–511. https://doi.org/10.1007/s00464-015-4232-8

    Article  PubMed  Google Scholar 

  65. D’Ambrosio G, Picchetto A, Campo S et al (2018) Quality of life in patients with loco-regional rectal cancer after ELRR by TEM versus VLS TME after nChRT: long-term results. Surg Endosc Epub ahead. https://doi.org/10.1007/s00464-018-6583-4

    Article  Google Scholar 

  66. Rombouts AJM, Al-Najami I, Abbott NL et al (2017) Can we S ave the rectum by watchful waiting or TransAnal microsurgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study. BMJ Open 7(12):1–8. https://doi.org/10.1136/bmjopen-2017-019474

    Article  Google Scholar 

  67. Serra-Aracil X, Pericay C, Golda T, Mora L, Targarona E, Delgado S (2018) Non-inferiority multicenter prospective randomized controlled study of rectal cancer T 2–T 3 s (superficial) N 0, M 0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME). Int J Colorectal Dis 33:241–249

    Article  CAS  PubMed  Google Scholar 

  68. Battersby NJ, Dattani M, Rao S et al (2017) A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol. Trials 18(394):1–14. https://doi.org/10.1186/s13063-017-2085-2

    Article  Google Scholar 

  69. Garcia-Aguilar J, Chen Z, Smith DD et al (2011) Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer. Ann Surg 254(3):486–493. https://doi.org/10.1097/sla.0b013e31822b8cfa

    Article  PubMed  Google Scholar 

  70. Chow OS, Kuk D, Keskin M et al (2016) KRAS and combined KRAS/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy. Ann Surg Oncol 23(8):2548–2555. https://doi.org/10.1245/s10434-016-5205-4

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy

    Roberto Peltrini, Michele Sacco, Gaetano Luglio & Luigi Bucci

Authors
  1. Roberto Peltrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michele Sacco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gaetano Luglio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luigi Bucci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Peltrini.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This article does not contain any studies with animals performed by any of the authors.

Informed consent

The informed consent does not apply since this is a review study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peltrini, R., Sacco, M., Luglio, G. et al. Local excision following chemoradiotherapy in T2–T3 rectal cancer: current status and critical appraisal. Updates Surg 72, 29–37 (2020). https://doi.org/10.1007/s13304-019-00689-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-019-00689-2

Keywords

Search

Navigation